Research institutions predict that Thailand's economy will grow by 2.4% in 2025. Thailand Kaitai Research Center released a report on the 13th, saying that it predicted that Thailand's gross domestic product (GDP) will increase by 2.4% in 2025, slightly lower than the growth forecast of 2.5% in 2024. The Kaitai Research Center believes that the slowdown in Thailand's economic growth is mainly due to the weakening of tourism, and it is expected that Thailand's exports to the US market will slow down. (Zhongxin. com)The yield of German 10-year government bonds is the biggest weekly increase since mid-April. The yield of German 10-year government bonds hit the highest level since November 25th, at 2.233%.Unitedhealth group, USA: The suspect in the executive shooting was not a corporate client. On December 13th, a spokesman for unitedhealth group said that Luigi Man Ghione, the suspect in the shooting of Brian Thompson, CEO of United Health Insurance Company, was not a corporate client. Andrew Vitti, CEO of unitedhealth group, expressed his condolences over Thompson's murder in a commentary and said that he understood the public's dissatisfaction with the "defective" health care system in the United States. Vitti said: "Health care is both a personal matter and very complicated. People don't fully understand the reasons behind the underwriting decision, and we are responsible for it. We need to work with employers, governments and other people who pay for medical expenses to improve the way we explain insurance coverage and make decisions. "
Puyin AXA Fund: Zhang Jian is the new chairman of the company. On December 13th, Puyin AXA Fund announced that since December 13th, Zhang Jian has been the new chairman of the company, while Xie Wei, the former chairman, left his post on December 13th due to work arrangements, and there is no explanation for his transfer to other positions in the company.Guangyunda: It is planned to raise no more than 448.9 million yuan from Junguang Investment. Guangyunda announced that the type of shares to be issued by the company to a specific target is domestic listed RMB ordinary shares (A shares) with a par value of RMB 1.00 per share. The object of issue is Shenzhen Junguang Investment Holding Co., Ltd., and the issue price is determined to be 7.74 yuan/share. The number of shares issued this time does not exceed 58 million shares (inclusive), which does not exceed 30% of the total share capital of the company before this issuance. The total amount of funds raised by the proposed stock issue to a specific target does not exceed RMB 448.92 million (inclusive), and the net amount of funds raised after deducting the issuance expenses is intended to be used to supplement the working capital. This proposal still needs to be submitted to the company's shareholders' meeting for consideration.Kaitou Macro: There is no end in sight for the industrial difficulties in the euro zone. Jack Allen-Reynolds, a macro economist at Kaitou, said in a report that the stagnation of industrial production in the euro zone in October shows that its industrial sector is still weak and will continue to struggle. In fact, he said, without Ireland's data, the G-20' s constant production data would look much worse, or it would drop by 0.5% month-on-month, while Ireland's data is notoriously unstable. Allen-Reynolds said that the output in October excluding Ireland decreased by 2.8% compared with the same period of last year, which was 18% lower than the output level of energy-intensive industries before the outbreak of the conflict between Russia and Ukraine. He said that automobile production is 17% lower than the pre-epidemic level. Although the production performance of other industries is not so bad, the latest survey shows that the overall industrial production continues to decline.
Market news: Brazilian President Luiz Inacio Lula da Silva entered the semi-intensive care unit for recovery after surgery.The Dow Jones Industrial Average is now at 43,917.68 points, up 3.56 points.Mckinsey agreed to pay $650 million to settle the criminal investigation of opioids by the U.S. Department of Justice. Mckinsey submitted a five-year deferred prosecution agreement to the federal court in Abingdon, Virginia, and agreed to pay $650 million to settle the criminal investigation of the U.S. Department of Justice on its work in guiding the opioid manufacturer Purdue Pharmaceutical to increase sales. According to court documents, Martin Elling, a former senior partner of McKinsey, agreed to plead guilty to obstruction of justice because he destroyed McKinsey's consulting records for Purdue Pharmaceutical. He will plead guilty on January 10th next year. Mckinsey has previously reached various settlement agreements totaling nearly $1 billion. The company had previously faced lawsuits in several States in the United States, and was accused of providing sales analysis and marketing advice to pharmaceutical companies such as Purdue Pharmaceutical and Johnson & Johnson, which contributed to the popularity of opioids.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14